Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - OTHER OPERATING ACTIVITIES
Other Operating Activities ELVN - Enliven Therapeutics, Inc.
-4.3 M
LAST VALUE
-45.88%
2 YEAR CAGR
-43.42%
5 YEAR CAGR
0.00%
10 YEAR CAGR